Atlas Trials

Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis

Clinical trial NCT02160665 · COMPLETED

Trial details

NCT number
NCT02160665
Sponsor
G & W Laboratories Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Plaque Psoriasis
Start date
2014-05-01
Primary completion
2016-05-01
Enrollment
866

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.